|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevention of type 2 diabetes with troglitazone in the diabetes prevention program显示文摘 | The Diabetes Prevention Program Research Group | 2005 | Diabetes2005，54，4： | 1 |
| 2 | The diabetes pre- vention program:Baseline characteristics of the randomized cohort显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，11： | 1 |
| 3 | Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program显示文摘 | The Diabetes Prevention Program Research Group | 2005 | Diabetes Care2005，28，： | 1 |
| 4 | Lipid,lipoproteins,C reactive protein,and hemostatic factors atbaseline in the diabetes prevention program显示文摘 | The Diabetes Prevention Program Research Group | 2005 | Diabetes Care2005，28，10： | 1 |
| 5 | The Diabetes Prevention Program显示文摘 | The Diabetes Prevention Program Research Group | 1999 | Diabetes Care1999，22，4： | 1 |
| 6 | The effects of intensive lifestyle intervention (ILS) and metformin (MET)on C-reactive protein (CRP), tissue plasminogen activator(TPA) and fibrinogen (FIB) in the Diabetes Prevention Program(DPP)显示文摘 | The Diabetes Prevention Program Research Group | 2003 | Diabetes2003，52，： | 1 |
| 7 | The diabetes prevention program-design and methods for a clinical trial in the prevention of type 2 diabetes显示文摘 | | 1999 | Diabetes Care1999，22，： | 1 |
| 8 | The Diabetes Prevention Program (DPP): description of lifestyle intervention显示文摘 | The Diabetes Prevention Program Research Group | 2002 | Diabetes Care2002，25，12： | 1 |
| 9 | The diabetes prevention program:base line characteristics of the randomized cohort显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，： | 1 |
| 10 | Report of expert committee on the diagnosis and classification of diabetes mellitus 显示文摘 | The Diabetes Prevention Program Research Group | 1997 | Diabetes Care1997，20，7： | 1 |
| 11 | Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program显示文摘 | The Diabetes prevention Program Research Group | 2005 | Diabetes care2005，28，： | 1 |
| 12 | The diabetes prevention program: baseline characteristics of the randomized cohort 显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，11： | 1 |
| 13 | Hypertension,insulin,and proinsulin in participants with impaired glucose tolerance显示文摘 | | 2002 | Hypertension2002，40，5： | 1 |
| 14 | The diabetes prevention program : Baseline characteristics of the randomized cohort显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，11： | 1 |
| 15 | The diabetes prevention program; baseline charateristics of the randomized cohort显示文摘 | The diabetes prevention program research group | 2000 | Diabetes Care2000，23，11： | 1 |
| 16 | The diabetes prevention program: Baseline characteristics of the randomized co- hort 显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes care2000，23，： | 1 |
| 17 | Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study 显示文摘 | The Diabetes Prevention Program Research Group | 2012 | Diabetes Care2012，35，4： | 1 |
| 18 | The diabetes prevention program: baseline characteristics of the randomized cohort 显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，11： | 1 |
| 19 | The diabetes pre- vention program: baseline characteristics of the randomized cohort 显示文摘 | The Diabetes Prevention Program Research Group | 2000 | Diabetes Care2000，23，11： | 1 |
| 20 | The Diabetes Prevention Program:Description of life style intervention显示文摘 | The Diabetes Prevention Program Research Group | 2002 | Diabetes Care2002，25，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员